Search results
Allergan is now part of AbbVie. We discover and develop innovative medicines for tomorrow, while helping people live better lives today.
- Careers Job Search
Allergan Aesthetics Job Type Full-time Function Allergan...
- Patients
From drug discovery and development to ensuring our...
- Pipeline
AbbVie will continue to support Calico in its early R&D...
- Partner With Us
AbbVie Ventures We strategically invest in transformational...
- Science
At AbbVie, our R&D teams are chasing bold goals. We are...
- Sustainability
2023 marked the close of our historic five-year, $350...
- Accessibility Statement
Please let us know if you encounter any accessibility issues...
- News Center
AbbVie (NYSE: ABBV) will announce its second-quarter 2024...
- Careers Job Search
May 8, 2020 · AbbVie Completes Transformative Acquisition of Allergan. - Creates biopharmaceutical company with leadership positions in key therapeutic areas: Immunology, Hematologic Oncology, Neuroscience, and Allergan Aesthetics. - Robust portfolio of on-market and pipeline assets well-positioned for sustainable long-term growth.
Allergan Aesthetics | An AbbVie Company. Empowering confidence. Choices backed by science. Learn More. Actual Patients. We create the products and technologies that drive the advancement of aesthetic medicine.
Learn how AbbVie successfully merged with Allergan in 2020 to create a larger, stronger and more diversified global biopharmaceutical company. The CEO shares the three critical factors that drove the transformational acquisition: shared purpose, innovation and culture.
statements in this presentation could cause AbbVie’s plans with respect to AbbVie, Allergan’s or AbbVie’s actual results, performance or achievements, industry results and developments to differ
May 8, 2020 · Allergan plc (NYSE: AGN) ("Allergan") announced that AbbVie has now completed the acquisition of Allergan pursuant to a scheme of arrangement under Chapter 1 of Part 9 of the Irish Companies Act 2014 (the "Scheme"), which became effective earlier today, May 8, 2020.
AbbVie and Allergan are now one company, bringing together over 30 brands and leadership positions in various therapeutic areas. The new AbbVie is committed to innovative science, profitable growth and global impact.